Utility of circulating tumor DNA for predicting prognosis in the management of resectable pancreatic cancer

被引：0
|
作者：
Tyerman, Zachary [1 ]
Ambler, Emily [2 ]
Schlick, Cary Jo R. [1 ]
Nwajei, Felix [4 ]
Chawla, Akhil [1 ,2 ,3 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA
[2] Northwestern Univ, Div Surg Oncol, Dept Surg, Northwestern Med Reg Med Grp,Feinberg Sch Med, Chicago, IL 60190 USA
[3] Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[4] Duke Univ, Sch Med, Dept Neurol, Durham, NC 27710 USA
来源：
JOURNAL OF CANCER METASTASIS AND TREATMENT | 2022年 / 8卷
关键词：
Pancreatic cancer; circulating tumor DNA; prognosis; survival; DUCTAL ADENOCARCINOMA; DIAGNOSIS; MARKER; RESISTANCE; MUTATIONS; CA19-9; PLASMA; BLOOD; SERUM;
D O I：
10.20517/2394-4722.2022.20
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: The measurement of circulating tumor DNA (ctDNA) has been studied in several malignancies, including metastatic pancreatic cancer, but less is known about its utility in monitoring treatment response and recurrence in resectable pancreatic cancer. Methods: We conducted a systematic review of the literature examining the association of ctDNA with overall survival (OS) and disease-free survival. Results: Five articles met our exclusion criteria. Baseline and/or postoperative ctDNA was found to be associated with decreased OS and recurrence-free survival. Discussion: ctDNA has the potential to be used as a prognostic biomarker and to guide therapy in resectable pancreatic cancer.
引用
收藏
页数：9
相关论文
共 50 条
  • [21] Utility of targeted deep sequencing for detecting circulating tumor DNA in pancreatic cancer patients
    Gahee Park
    Joo Kyung Park
    Dae-Soon Son
    Seung-Ho Shin
    Yeon Jeong Kim
    Hyo-Jeong Jeon
    Jae Lee
    Woong-Yang Park
    Kwang Hyuck Lee
    Donghyun Park
    Scientific Reports, 8
  • [22] Clinical Utility of Circulating Tumor DNA for Molecular Assessment and Precision Medicine in Pancreatic Cancer
    Takai, Erina
    Totoki, Yasushi
    Nakamura, Hiromi
    Kato, Mamoru
    Shibata, Tatsuhiro
    Yachida, Shinichi
    CIRCULATING NUCLEIC ACIDS IN SERUM AND PLASMA - CNAPS IX, 2016, 924 : 13 - 17
  • [23] Circulating tumor DNA dynamics in resectable gastric cancer.
    Leal, Alessandro
    van Grieken, Nicole C. T.
    Phallen, Jillian
    Palsgrove, Doreen N.
    Adleff, Vilmos
    Warmerdam, Fabienne
    Van der Peet, Donald L.
    Verheul, Henk M. W.
    Van Spronsen, D. J.
    Van Riel, Johanna M. G.
    Geenen, Maud
    Portielje, Johanna Elisabeth A.
    Van Laarhoven, Hanneke W. M.
    Jansen, Edwin P. M.
    Sikorska, Karolina
    Kranenbarg, Elma Meershoek-Klein
    Van De Velde, Cornelis J. H.
    Verheij, Marcel
    Cats, Annemieke
    Velculescu, Victor E.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [24] Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer
    Riva, Francesca
    Dronov, Oleksii I.
    Khomenko, Dmytro I.
    Huguet, Florence
    Louvet, Christophe
    Mariani, Pascale
    Stern, Marc-Henri
    Lantz, Olivier
    Proudhon, Charlotte
    Pierga, Jean-Yves
    Bidard, Francois-Clement
    MOLECULAR ONCOLOGY, 2016, 10 (03) : 481 - 493
  • [25] Clinical utility of circulating tumor DNA for colorectal cancer
    Osumi, Hiroki
    Shinozaki, Eiji
    Yamaguchi, Kensei
    Zembutsu, Hitoshi
    CANCER SCIENCE, 2019, 110 (04) : 1148 - 1155
  • [26] Clinical utility of circulating tumour DNA (ctDNA) in resectable gastric cancer (GC)
    Fedyanin, M.
    Ignatova, E.
    Boyarskikh, U.
    Polyanskaya, E.
    Kechin, A.
    Osccorobin, I.
    Shamovskaya, D.
    Popova, A.
    Trigolosov, A.
    Nikulin, M.
    Nered, S.
    Kalinin, A.
    Stilidi, I.
    Moroz, E.
    Filipenko, M.
    Tjulandin, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S1295 - S1295
  • [27] Circulating tumor DNA in cancer diagnosis, monitoring, and prognosis
    Saha, Sudeepto
    Araf, Yusha
    Promon, Salman Khan
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2022, 34 (01)
  • [28] Circulating tumor DNA in cancer diagnosis, monitoring, and prognosis
    Sudeepto Saha
    Yusha Araf
    Salman Khan Promon
    Journal of the Egyptian National Cancer Institute, 34
  • [29] Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells
    Yeo, Dannel
    Bastian, Althea
    Strauss, Heidi
    Saxena, Payal
    Grimison, Peter
    Rasko, John E. J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [30] The Value of Circulating Tumor Cells in the Prognosis and Treatment of Pancreatic Cancer
    Luo, Kai
    Wang, Xiangkun
    Zhang, Xudong
    Liu, Zhongyuan
    Huang, Shuai
    Li, Renfeng
    FRONTIERS IN ONCOLOGY, 2022, 12
12345